1. Fang, Ye-Ying, Ma, Fu-Chao, Gan, Xu-Li, Wei, Dan-Ming, Hu, Xiao-Hua. 2018. Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study. In International journal of clinical and experimental pathology, 11, 1318-1327. doi:. https://pubmed.ncbi.nlm.nih.gov/31938227/
2. Dewdney, Summer B, Rimel, B J, Thaker, Premal H, Gao, Feng, Goodfellow, Paul J. 2011. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers. In Clinical cancer research : an official journal of the American Association for Cancer Research, 17, 2120-9. doi:10.1158/1078-0432.CCR-10-2668. https://pubmed.ncbi.nlm.nih.gov/21372219/
3. Xue, Ji, Yang, Guang, Ding, Hong, Wang, Pu, Wang, Changhong. 2015. Role of NSC319726 in ovarian cancer based on the bioinformatics analyses. In OncoTargets and therapy, 8, 3757-65. doi:10.2147/OTT.S86343. https://pubmed.ncbi.nlm.nih.gov/26719703/
4. Xi, Ting, Zhang, Guizhi. 2016. Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma. In Pathology, research and practice, 213, 83-88. doi:10.1016/j.prp.2016.12.007. https://pubmed.ncbi.nlm.nih.gov/28049580/
5. He, Shuai, Lu, Ming, Zhang, Liang, Wang, Zhe. 2023. RSK4 promotes the macrophage recruitment and M2 polarization in esophageal squamous cell carcinoma. In Biochimica et biophysica acta. Molecular basis of disease, 1870, 166996. doi:10.1016/j.bbadis.2023.166996. https://pubmed.ncbi.nlm.nih.gov/38142759/